Robert Baltera Jr.
Director · PALISADE BIO, INC.
- 2026
- Jul 10, 2026
- 4
Summary
Latest filing:
Robert Baltera Jr. is Director of PALISADE BIO, INC. (PALI). 4 SEC Form 4 filings on record, most recently on 10 July 2026. Most recent open-market trade: bought $49K of PALI on 10 July 2026. Lifetime open-market purchases: $250K.
Recent transactions
7The latest 7 SEC Form 4 transactions reported by Robert Baltera Jr..
Trading pattern
InsiderAlpha's records for Robert Baltera Jr. go back to 2026: 4 primary Form 4 filings, an average of 4.0 per year. The typical open-market purchase is $42K (6 buys totaling $250K). The largest single buy on record is $61K of PALI in 2026. No recorded transaction carries a Rule 10b5-1 plan flag. An absent flag does not establish whether a transaction was pre-arranged or discretionary.
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Robert Baltera Jr. files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- John David Finley - $310K in PALI purchases and sales in the last 12 months
- Mitchell Lawrence Jones - $110K in PALI purchases and sales in the last 12 months
- Donald Allen Williams - $47K in PALI purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Robert Baltera Jr.?
Robert Baltera Jr. is a corporate insider, tracked as Director of PALISADE BIO, INC. (PALI). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Robert Baltera Jr. last file a Form 4?
The most recent primary Form 4 on record is dated 10 July 2026, one of 4 filings going back to 2026.
Has Robert Baltera Jr. been buying or selling stock?
Recorded transactions: 6 open-market purchases ($250K) and 0 open-market sales across all tracked filings.